TABLE 3.
Multivariate logistic regression model of factors associated with AKI using peak Scr
| Factor | OR | 95% CI | P value |
|---|---|---|---|
| Remdesivir solution formulation | 1.05 | 0.49–2.29 | 0.901 |
| Medical history of hypertension | 1.09 | 0.49–2.53 | 0.843 |
| Mechanical ventilation during remdesivir | 4.33 | 1.35–13.05 | 0.012 |
| Vasopressor or inotrope use during remdesivir | 4.65 | 1.51–14.8 | 0.009 |
| Older age | 1.02 | 0.99–1.05 | 0.199 |
| CrCl < 30 ml/min on the day of remdesivir initiation | 1.39 | 0.51–3.5 | 0.499 |
| Days of symptom onset to remdesivir administration | 1.01 | 0.94–1.06 | 0.819 |